
Androlabs has received UK marketing authorisation for a new presentation of Testavan 4.6 mg/actuation transdermal gel for testosterone replacement therapy …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

